DNB Aktiv 80 A vs UBS Lux Equity Fund Biotech USD

DNB Aktiv 80 A vs UBS Lux Equity Fund Biotech USD

1. DNB Aktiv 80 A

  • Security

    DNB Aktiv 80 A

  • Fee

    1.04%

  • ISIN

    NO0010337793

  • Holdings

    3

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 3 holdings in DNB Aktiv 80 A, where the largest holding is Proethos Fond (19.72), followed by Alfred Berg Optimal D (5.4) and Nordnet One Offensiv (2.9). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in DNB Aktiv 80 A and UBS Lux Equity Fund Biotech USD.

DNB Aktiv 80 A UBS Lux Equity Fund Biotech USD
1. Proethos Fond
Sweden
19.72 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Alfred Berg Optimal D
5.4 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Nordnet One Offensiv NOK
Sweden
2.9 %
3. Moderna Inc
9.21 %
- 4. Alnylam Pharmaceuticals Inc
6.54 %
- 5. AbbVie Inc
USA
5.52 %
- 6. Gilead Sciences Inc
USA
4.66 %
- 7. Amgen Inc
4.32 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 17, 2025.